Evaluating peripheral retinal vascularization and rate of recurrence after intravitreal injection of ranibizumab as a primary treatment for retinopathy of prematurity

Evaluating peripheral retinal vascularization and rate of recurrence after intravitreal injection of ranibizumab as a primary treatment for retinopathy of prematurity

Context Retinopathy of prematurity (ROP) is a vascular proliferative disease affecting premature infants. Aims The aim was to assess the extent of peripheral retinal vascular growth and recurrence rate in patients with type 1 ROP treated with ranibizumab. Settings and design Patients with ROP atte...

Full description

Bibliographic Details
Main Authors: Mostafa M El Manhaly, Ossama A El Hadad, Hesham F Goweini, Ahmed A Souka
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of the Egyptian Ophthalmological Society
Subjects:
ranibizumab
retinopathy of prematurity
Online Access:http://www.jeos.eg.net/article.asp?issn=2090-0686;year=2020;volume=113;issue=4;spage=125;epage=132;aulast=El

Internet

http://www.jeos.eg.net/article.asp?issn=2090-0686;year=2020;volume=113;issue=4;spage=125;epage=132;aulast=El

Similar Items